Skip to main content

Table 2 Treatment efficacy represented as cell survival relative to the respective solvent control

From: Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids

  1. Mean values are shown in the breast cancer spheroid model for patient samples grouped according to clinical criteria, primary and recurrent tumors are included
  2. Significant differences between clinical subgroups in treatment efficacy are highlighted in dark grey with bold font
  3. * p < 0.05, ** p < 0.001
  4. HR hormone receptor, ER estrogen receptor, PR progesterone receptor, cps counts per second, 5-FU 5-fluorouracil, Crbp carboplatin, Doc docetaxel, Pac paclitaxel, EC epirubicin + cyclophosphamide, DocAC docetaxel + doxorubicin + cyclophosphamide, FEC 5-fluorouracil + epirubicin + cyclophosphamide, nd not done
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us